Home
About
Overview
Sharing Data
ORCID
Help
History (69)
Psychological Tests
Experimentally induced nasal allergic responses.
Intermittent hypoxia augments carotid body and ventilatory response to hypoxia in neonatal rat pups.
In vivo demonstration of inflammatory mediator release following nasal challenge with antigen.
Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?
See All 69 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?
Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II? Clin Cancer Res. 2012 May 15; 18(10):2809-16.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials, Phase II as Topic
Humans
Medical Oncology
Neoplasms
Pharmacogenetics
Randomized Controlled Trials as Topic
authors with profiles
Peter O'Donnell